AVMA news
Sales, distribution of medically important antimicrobials remain down for food animals
Annual sales and distribution by volume of medically important antimicrobials for food-producing animals remain down since the substantial decrease in…
AVMA news
USDA developing new tools to identify SARS-CoV-2 in wild, domestic animals
U.S. Department of Agriculture scientists are developing new tests and tools to identify and track the SARS-CoV-2 virus and its variants in wild and…
AVMA news
Congress approves development of national One Health coordination plan, other veterinary funding priorities
Language supported by the AVMA in new legislation will coordinate federal activities aimed at combating zoonotic disease outbreaks. The measure was…
blog
Congressional offices consider making xylazine a controlled substance
With illicit xylazine increasingly showing up in street drugs that pose grave risks to human users, government policymakers are discussing making it a…
AVMA news
USDA proposed rulemaking to strengthen regulations for handling wild, exotic animals
The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service is soliciting public comment on a plan to strengthen regulations for…
AVMA news
FDA issues guidance on preventing drug carryover during manufacturing of animal food
The Food and Drug Administration issued guidance that compiles established practices that manufacturers of medicated animal food can use to prevent…
Animal health advocacy
The AVMA’s advocacy work provides critical support for the work veterinary teams do every day to protect, promote, and advance animal health. Learn…
AVMA news
Forfa named new director of FDA Center for Veterinary Medicine
Tracey Forfa, a 30-year veteran of the Food and Drug Administration’s Center for Veterinary Medicine, succeeds Dr. Steven Solomon, who retired as…
blog
AVMA backing helps reignite push for stronger dog import standards
The Healthy Dog Importation Act would strengthen importation standards to ensure that all dogs entering the country are healthy and not at risk to…
AVMA news
FDA: Congress, not rule-making, likely route for CBD availability
With the cannabidiol products market continuing to grow and after reviewing published scientific literature and information submitted to a public…
AVMA news
Remaining medically important antimicrobials transitioning to prescription status
The Food and Drug Administration is reminding stakeholders that certain over-the-counter antimicrobial products for animals are transitioning to…
AVMA news
FDA concludes first premarket consultation for meat cultured from animal cells
In a historic move, the Food and Drug Administration’s premarket consultation for meat cultured from animal cells brings Upside Foods’ chicken closer…
AVMA news
New law clarifies alternatives to animal testing for safety, efficacy of drugs
The recently passed FDA Modernization Act 2.0 authorizes the use of certain alternatives to animal testing, including cell-based assays and computer…
blog
AVMA endorses federal legislation to address illicit xylazine
The bill would equip law enforcement with additional tools to stop illegal xylazine trafficking while protecting veterinarians’ access to this…
AVMA news
AVMA testifies in support of improving new animal drug review efficiency
AVMA President Lori Teller appeared before a House subcommittee to urge reauthorization of legislation supporting approval of new and generic animal…
AVMA news
USDA finalizes standards to include birds under Animal Welfare Act
The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service is establishing welfare standards for birds, which were previously…
AVMA news
EPA, FDA weigh oversight overhaul for animal parasite products
Two federal agencies are considering transferring oversight of some 600 products from the Environmental Protection Agency (EPA) to the Food and Drug…
AVMA news
AVMA members press Congress for illicit xylazine, dog importation laws
Nearly 120 veterinarians and veterinary students attended the 2023 AVMA annual legislative fly-in, held April 17-19 in Washington, D.C. They urged…
AVMA news
Canine osteoarthritis drug, Lyme disease bacteria vaccine receive approvals
Two recent drug approvals mean a novel treatment for the control of canine osteoarthritis (OA) pain and an oral vaccine against the wildlife spread of…
AVMA news
Beef cow with atypical bovine spongiform encephalopathy found in South Carolina
A beef cow at a slaughter plant in South Carolina tested positive for an atypical case of bovine spongiform encephalopathy (BSE), according to a May…
AVMA selects 2023-2024 congressional fellow
The AVMA announced that veterinarian Dr. Mariah Lancaster of Massachusetts has been selected to participate in the 2023-2024 AVMA Fellowship Program.
AVMA news
Midwest Veterinary Supply sentenced to one year probation, pays $11M for misbranded drugs
Minnesota-based drug company Midwest Veterinary Supply recently was sentenced to one year of probation and agreed to pay more than $11 million in…
AVMA news
Advances in animal genome editing continue apace
The Food and Drug Administration (FDA) recently green lit for human consumption five genetically modified pigs at Washington State University.…
AVMA news
Educational debt repayment program awards $9M in 2022
In 2022, the Veterinary Medicine Loan Repayment Program (VMLRP) awarded nearly $9 million to 89 veterinarians in exchange for working in U.S.…
AVMA news
House Committee advances AVMA-backed xylazine language
The Administration announced its national coordinated response on July 11 to fight the deadly combination of illicit xylazine mixed with fentanyl.